van Ahlen H - Search Results

1

The real-life safety and efficacy of vardenafil: an international post-marketing surveillance study--results from 29 358 German patients.

van Ahlen H, Zumbé J, Stauch K, Landen H. van Ahlen H, et al. J Int Med Res. 2005 May-Jun;33(3):337-48. doi: 10.1177/147323000503300309. J Int Med Res. 2005. PMID: 15938595

2

[Rehabilitation of erectile function after nerve-sparing radical prostatectomy: therapeutic concepts in Germany].

Bannowsky A, Raileanu A, Uckert S, van Ahlen H. Bannowsky A, et al. Among authors: van ahlen h. Urologe A. 2013 Dec;52(12):1679-83. doi: 10.1007/s00120-013-3303-5. Urologe A. 2013. PMID: 24042489 German.

3

[Efficacy and safety of treatment of erectile dysfunction with Vardenafil under routine conditions].

Van Ahlen H, Zumbé J, Stauch K, Landen H. Van Ahlen H, et al. MMW Fortschr Med. 2005 Oct 27;147(43):41. MMW Fortschr Med. 2005. PMID: 16302421 German. No abstract available.

4

Increasing the dose of vardenafil on a daily basis does not improve erectile function after unilateral nerve-sparing radical prostatectomy.

Bannowsky A, van Ahlen H, Loch T. Bannowsky A, et al. Among authors: van ahlen h. J Sex Med. 2012 May;9(5):1448-53. doi: 10.1111/j.1743-6109.2012.02705.x. Epub 2012 Mar 29. J Sex Med. 2012. PMID: 22462626 Clinical Trial.

5

The Real-Life Safety and Efficacy of vardenafil (REALISE) study: results in men from Europe and overseas with erectile dysfunction and cardiovascular or metabolic conditions.

Van Ahlen H, Zumbé J, Stauch K, Hanisch JU. Van Ahlen H, et al. J Sex Med. 2010 Sep;7(9):3161-9. doi: 10.1111/j.1743-6109.2010.01921.x. J Sex Med. 2010. PMID: 20646189

6

Efficacy and safety of flexible-dose vardenafil in men with type 1 diabetes and erectile dysfunction.

Ziegler D, Merfort F, Van Ahlen H, Yassin A, Reblin T, Neureither M. Ziegler D, et al. Among authors: van ahlen h. J Sex Med. 2006 Sep;3(5):883-891. doi: 10.1111/j.1743-6109.2006.00295.x. J Sex Med. 2006. PMID: 16942532 Clinical Trial.

7

Efficacy and safety of two dosing regimens of tadalafil and patterns of sexual activity in men with diabetes mellitus and erectile dysfunction: Scheduled use vs. on-demand regimen evaluation (SURE) study in 14 European countries.

Buvat J, van Ahlen H, Schmitt H, Chan M, Kuepfer C, Varanese L. Buvat J, et al. Among authors: van ahlen h. J Sex Med. 2006 May;3(3):512-20. doi: 10.1111/j.1743-6109.2006.00249.x. J Sex Med. 2006. PMID: 16681477 Clinical Trial.

8

Safety and efficacy of vardenafil, a selective phosphodiesterase 5 inhibitor, in patients with erectile dysfunction and arterial hypertension treated with multiple antihypertensives.

van Ahlen H, Wahle K, Kupper W, Yassin A, Reblin T, Neureither M. van Ahlen H, et al. J Sex Med. 2005 Nov;2(6):856-64. doi: 10.1111/j.1743-6109.2005.00150.x. J Sex Med. 2005. PMID: 16422810 Clinical Trial.

9

Opiate antagonists in erectile dysfunction: a possible new treatment option? Results of a pilot study with naltrexone.

van Ahlen H, Piechota HJ, Kias HJ, Brennemann W, Klingmüller D. van Ahlen H, et al. Eur Urol. 1995;28(3):246-50. doi: 10.1159/000475059. Eur Urol. 1995. PMID: 8536780 Clinical Trial.

10

Treatment of idiopathic erectile dysfunction in men with the opiate antagonist naltrexone--a double-blind study.

Brennemann W, Stitz B, Van Ahlen H, Brensing KA, Klingmüller D. Brennemann W, et al. Among authors: van ahlen h. J Androl. 1993 Nov-Dec;14(6):407-10. J Androl. 1993. PMID: 8294223 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results